共查询到19条相似文献,搜索用时 250 毫秒
1.
以具有活血化瘀作用的中药有效成分阿魏酸为先导物,利用基于受体结构的理性药物设计方法,设计并合成了6个新化合物[(吡嗪-3-基)甲氧基]芳酸衍生物(6a~6f)。以2-甲基吡嗪和不同取代的芳香酸甲酯为起始原料,经自由基卤代反应、醚化反应和水解反应合成6a~6f,其结构经1H NMR, 13C NMR, IR和MS表征。体外药效筛选结果显示:6a~6f具有明显的抗血小板聚集活性,其中(E)-3-甲氧基-4-(吡嗪-2-甲氧基) 苯丙烯酸(6a)和3-(2-吡嗪甲氧基)-4-甲氧基-苯甲酸(6e)的活性优于奥扎格雷和阿魏酸。(E)-3-甲氧基-4-(吡嗪-2-甲氧基)-苯丙烯酸(6a)的抗血小板聚集活性,优于化合物(E)-3-(4-(吡啶-3-基)甲氧基)-3-甲氧基苯基)丙烯酸。 相似文献
2.
3.
以N-甲基-4-硝基苯胺作为起始原料,依次经氯乙酰化、取代及氢化还原反应制得关键中间体N-(4-氨基苯基)-甲基-2-(4-甲基-1-哌嗪基)乙酰胺(4);以4-氯-3-硝基苯甲酸为原料,依次经酯化、取代、氢化还原及环合反应制得6-甲氧羰基-2-吲哚酮(8); 8与原苯甲酸三乙酯和乙酸酐经“一锅煮”反应制得中间体1-乙酰基-3-甲氧基(苯基)亚甲烯基-2-氧代吲哚环-6-羧酸甲酯(9); 4和9进行取代反应的同时脱除保护,经“一锅煮”反应合成尼达尼布,总收率57.2%,其结构经1H NMR,13C NMR和MS(ESI)确证。 相似文献
4.
以2-氨基-4-甲氧基苯甲酸甲酯为原料,通过氯代反应,再分别通过酯水解反应得到化合物2-氨基-5-氯-4-甲氧基苯甲酸和2-氨基-3-氯-4-甲氧基苯甲酸。其中间体及产物结构经~1H NMR、~(13)C NMR和ESI-MS确证,并考察了最佳氯代反应条件。结果表明:物料配比为n(2-氨基-4-甲氧基苯甲酸甲酯)∶n(NCS)=1∶1. 2,反应溶剂为N,N-二甲基甲酰胺,反应时间为16 h,两种氯代产物2-氨基-5-氯-4-甲氧基苯甲酸甲酯和2-氨基-3-氯-4-甲氧基苯甲酸甲酯收率分别为47%和39%。 相似文献
5.
以7-羟甲基-1-四氢萘酮和1-溴-4-氯-苯甲醛为起始原料,经14步反应合成了抗丙肝新药维拉帕维--甲基(2S)-1-【(2S,5S)-2-【9{2[(2S,4S)-1-(2R)-2-[(甲氧基羰基)氨基]-2-苯乙酰基-4-(甲氧基甲基)吡咯烷-2-基]-1H-咪唑 5 基} 1,11-二氢异色烯[4′,3′ :6,7]萘并[1,2-d]咪唑-2-基-5-甲基吡咯烷-1-基】-3-甲基-1-氧丁烷-2-基】氨基甲酸酯,总产率10.14%,其结构经1H NMR和ESI-MS确证。 相似文献
6.
聚合反应制备键合型纤维素-三(4-甲基苯基甲酸酯)衍生物类手性固定相 总被引:3,自引:0,他引:3
合成了带有甲基丙烯酰基的纤维素-三(4-甲基苯基甲酸酯)衍生物(CTMB),并通过聚合反应将其键合在具有双键的硅胶表面,得到手性固定相(CSP)。用所得到的CSP对9种对映体化合物(丁苯酞、酮基布洛芬、反-2,3-二苯环氧乙烷、安息香、安息香类似物、托葛尔碱、华法令、4,4′-二甲氧基-5,6,5′,6′-二次甲二氧基-2,2′-羰甲基甲酯联苯、4,4′-二甲氧基-5,6,5′,6′-二次甲二氧基-2-羰甲基甲酯-2′-羰甲基乙酯联苯)进行了拆分。考察了CSP制备过程中甲基丙烯酰氯的用量、键合方式以及硅胶 相似文献
7.
8.
9.
10.
以3-硝基-2-氨基苯甲酸甲酯为原料,经三氟乙酰化、N-烷基化和脱保护反应制得坎地沙坦中间体2-{[(2'-氰基联苯基-4-基)甲基]氨基}-3-硝基苯甲酸甲酯,其结构经~1H NMR,~(13)C NMR和MS(ESI)确证。 相似文献
11.
A chromatographic procedure for the preparative isolation of six different 6-alkylsalicylic acids (syn. ginkgolic acids) with as alkyl substituents C13:0, C15:0, C15:1, C17:1, C17:2 and, tentatively C17:3 from Ginkgo biloba leaves was developed. The procedure consisted of a combination of normal-phase, reversed-phase and argentation chromatography. The compounds were characterised by means of UV, 1H-NMR and 13C-NMR spectroscopy, and mass spectrometry after silylation. A 15 cm C18 RP-HPLC column connected in series with a 20 cm silver(I) loaded cation exchanger HPLC column in combination with the solvent methanol–water (93:7) acidified with 0.1% formic acid was capable of separating the ginkgolic acids C13:0, C15:1, C17:2, C15:0 and C17:1 within 21 min on an analytical scale. The separation is based on a combination of reversed-phase mechanisms and double bond complexation. Detection took place by UV at 311 nm. The separation is a good starting point for the development of a quantitative procedure for the five major ginkgolic acids in Ginkgo leaves and standardised extracts. 相似文献
12.
Preparative isolation and dual column high-performance liquid chromatography of ginkgolic acids from Ginkgo biloba. 总被引:3,自引:0,他引:3
A chromatographic procedure for the preparative isolation of six different 6-alkylsalicylic acids (syn. ginkgolic acids) with as alkyl substituents C13:0, C15:0, C15:1, C17:1, C17:2 and, tentatively C17:3 from Ginkgo biloba leaves was developed. The procedure consisted of a combination of normal-phase, reversed-phase and argentation chromatography. The compounds were characterised by means of UV, 1H-NMR and 13C-NMR spectroscopy, and mass spectrometry after silylation. A 15 cm C18 RP-HPLC column connected in series with a 20 cm silver(I) loaded cation exchanger HPLC column in combination with the solvent methanol–water (93:7) acidified with 0.1% formic acid was capable of separating the ginkgolic acids C13:0, C15:1, C17:2, C15:0 and C17:1 within 21 min on an analytical scale. The separation is based on a combination of reversed-phase mechanisms and double bond complexation. Detection took place by UV at 311 nm. The separation is a good starting point for the development of a quantitative procedure for the five major ginkgolic acids in Ginkgo leaves and standardised extracts. 相似文献
13.
报道了35,40-二羟基-6-甲氧基-藤黄酸甲酯(1)、9,10-二羟基-6-甲氧基-藤黄酸甲酯(2)和2-去异己烯-2-(2-甲酰基)乙基-6-甲氧基-藤黄酸甲酯(3)的化学合成和抗肿瘤活性. 采用二维定量构效关系方法经计算机模拟与统计分析, 获得定量构效关系方程. 结果显示, 藤黄酸氧化衍生物的极性体积比、零阶价分子连接性指数、总电荷绝对值和体积与抗肿瘤活性间表现出了良好的线性关系. 相似文献
14.
15.
16.
A method to determine alkylphenols in Ginkgo biloba sarcotesta, especially focusing on polyunsaturated ginkgolic acid components, was developed on the basis of thermochemolysis–gas chromatography/mass spectrometry with a DB-23 column in the presence of trimethylsulfonium hydroxide [(CH3)3SOH]. By using this technique, powder sample of Ginkgo biloba sarcotesta can be directly analyzed without any tedious and time-consuming pretreatment. On the resulting chromatograms, seven kinds of ginkgolic acids including polyunsaturated ginkgolic acid GA17:2 and two kinds of ginkgols were clearly observed as their methyl derivative. Based on the peak areas, the ginkgolic acid compositions are in good agreement with these obtained by a high-performance liquid chromatography method dedicated to analysis of ginkgolic acid. 相似文献
17.
以5-Cl水杨醛和L-苯丙氨酸、L-亮氨酸及L-甘氨酸的脂肪酸酯为原料,通过碱催化的席夫碱缩合反应,合成了6种N-(5-氯-2-羟苄基)席夫碱氨基酸酯及其还原产物N-(5-氯-2-羟苄基)氨基酸酯。 化合物的结构及组成经过IR、1H NMR和元素分析测试技术进行了表征。 合成的席夫碱及其还原产物对革兰氏阴性菌、革兰氏阳性菌及真菌均有不同程度的抑制作用。 质量分数为0.01%的N-(5-氯-2-羟苄基)席夫碱氨基酸酯对大肠杆菌的抑菌率达90%以上,而N-(5-氯-2-羟苄基)氨基酸酯对金黄色葡萄球菌的抑菌率也在90%以上,均为强抑菌活性,其中N-(5-氯-2-羟苄基)苯丙氨酸酯的抑菌率达98%以上。 相似文献
18.
19.
为了研究不同植物诱导剂之间的协同作用, 我们以水杨酸甲酯为原料与6-O-乙酰基-2,3,4-三-O-苯甲酰基-α-D-吡喃葡萄糖苷三氯乙酰亚胺酯偶联得化合物5, 然后脱去6-位乙酰基得受体化合物6, 化合物6与葡聚六糖三氯乙酰亚胺酯供体7偶联, 脱保护后得到葡聚七糖与水杨酸的缀合物1. 生物活性研究结果表明, 葡聚七糖还原端连有水杨酸的糖缀合物诱导植物抗病活性要比相应的七糖2高. 相似文献